• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨基质中破骨细胞招募活性

Osteoclast recruiting activity in bone matrix.

作者信息

Hentunen T A, Cunningham N S, Vuolteenaho O, Reddi A H, Väänänen H K

机构信息

Department of Anatomy, University of Oulu, Finland.

出版信息

Bone Miner. 1994 Jun;25(3):183-98. doi: 10.1016/s0169-6009(08)80238-3.

DOI:10.1016/s0169-6009(08)80238-3
PMID:8086857
Abstract

An activity that recruits osteoclasts has been identified and partially characterized from bone matrix. Bone-derived osteoclast recruiting activity (BORA) was co-purified with osteogenin, a bone inductive protein. Osteogenin was extracted from bovine bone with 6 M urea and purified by chromatography on hydroxyapatite, heparin-Sepharose and Sephacryl S-200 gel filtration. The biologically active osteoclast formation-stimulating material was further purified by C18 reverse phase HPLC. BORA is obviously distinct from osteogenin and transforming growth factor beta (TGF-beta), since further purified osteogenin and pure TGF-beta did not stimulate the formation of osteoclast-like cells. BORA (0.1-10 micrograms/ml) stimulated the formation of tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cells (MNC) in a dose-dependent manner. These multinucleated cells resorbed bone when cultured on bovine bone slices. The effect of BORA is primarily directed to differentiate osteoclast precursors, since it did not stimulate osteoclast function in in vitro resorption assay where disaggregated rat osteoclasts were cultured on bovine bone slices. However, after 24 h preincubation with 50 nM PTH in the mouse calvaria assay, BORA at 10 micrograms/ml significantly stimulated bone resorption.

摘要

一种可募集破骨细胞的活性物质已从骨基质中被鉴定出来,并对其进行了部分特性分析。骨源性破骨细胞募集活性物质(BORA)与骨生成素(一种骨诱导蛋白)共同纯化得到。骨生成素用6M尿素从牛骨中提取,然后通过羟基磷灰石、肝素-琼脂糖和Sephacryl S-200凝胶过滤色谱法进行纯化。具有生物活性的破骨细胞形成刺激物质通过C18反相高效液相色谱法进一步纯化。BORA明显不同于骨生成素和转化生长因子β(TGF-β),因为进一步纯化的骨生成素和纯TGF-β不会刺激破骨样细胞的形成。BORA(0.1-10微克/毫升)以剂量依赖的方式刺激抗酒石酸酸性磷酸酶(TRAP)阳性多核细胞(MNC)的形成。当这些多核细胞在牛骨切片上培养时会吸收骨质。BORA的作用主要是促使破骨细胞前体分化,因为在体外吸收试验中,当将分离的大鼠破骨细胞培养在牛骨切片上时,它不会刺激破骨细胞的功能。然而,在小鼠颅骨试验中用50 nM甲状旁腺激素(PTH)预孵育24小时后,10微克/毫升的BORA能显著刺激骨吸收。

相似文献

1
Osteoclast recruiting activity in bone matrix.骨基质中破骨细胞招募活性
Bone Miner. 1994 Jun;25(3):183-98. doi: 10.1016/s0169-6009(08)80238-3.
2
The purification and partial characterization of bone resorptive polypeptides from bovine bone matrix.从牛骨基质中纯化及部分鉴定骨吸收性多肽
Biochim Biophys Acta. 1994 Nov 11;1201(2):193-202. doi: 10.1016/0304-4165(94)90041-8.
3
Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation.骨基质中的骨钙素片段在破骨细胞分化后期增强破骨细胞成熟。
J Bone Miner Metab. 2004;22(5):415-29. doi: 10.1007/s00774-004-0503-5.
4
Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function.成骨细胞介导胰岛素样生长因子-I和-II对破骨细胞形成及功能的刺激作用。
Endocrinology. 1995 Jan;136(1):124-31. doi: 10.1210/endo.136.1.7828521.
5
Osteogenin, a bone morphogenetic protein, adsorbed on porous hydroxyapatite substrata, induces rapid bone differentiation in calvarial defects of adult primates.
Plast Reconstr Surg. 1992 Sep;90(3):382-93. doi: 10.1097/00006534-199209000-00004.
6
Inhibitory effects of the bone-derived growth factors osteoinductive factor and transforming growth factor-beta on isolated osteoclasts.骨源性生长因子骨诱导因子和转化生长因子-β对分离破骨细胞的抑制作用。
Endocrinology. 1990 Jun;126(6):3069-75. doi: 10.1210/endo-126-6-3069.
7
Inhibitory effect of interleukin-4 on osteoclast-like cell formation in mouse bone marrow culture.白细胞介素-4对小鼠骨髓培养中破骨细胞样细胞形成的抑制作用。
Bone Miner. 1993 Jun;21(3):179-88. doi: 10.1016/s0169-6009(08)80229-2.
8
Effects of recombinant human osteogenic protein-1 on the differentiation of osteoclast-like cells and bone resorption.重组人骨生成蛋白-1对破骨样细胞分化及骨吸收的影响
Biochem Biophys Res Commun. 1995 Apr 17;209(2):433-43. doi: 10.1006/bbrc.1995.1521.
9
Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.体外成骨细胞条件培养基诱导破骨样细胞过程中破骨细胞121F抗原表达:与降钙素反应性、抗酒石酸酸性磷酸酶水平及骨吸收活性的关系
J Bone Miner Res. 1995 Jan;10(1):45-58. doi: 10.1002/jbmr.5650100109.
10
Characterization of circulating human osteoclast progenitors: development of in vitro resorption assay.循环中的人破骨细胞祖细胞的特征:体外吸收测定法的建立
Calcif Tissue Int. 2005 Mar;76(3):222-30. doi: 10.1007/s00223-004-0123-z. Epub 2005 Feb 7.

引用本文的文献

1
Ameliorating orthodontic relapse using laser bio-stimulation and mesenchymal stem cells in rats.利用激光生物刺激和间充质干细胞改善大鼠正畸复发情况。
J Genet Eng Biotechnol. 2024 Mar;22(1):100331. doi: 10.1016/j.jgeb.2023.100331. Epub 2024 Jan 22.
2
The effects of low-level laser therapy on orthodontically induced root resorption.低强度激光疗法对正畸诱导牙根吸收的影响。
Lasers Med Sci. 2015 Nov;30(8):2067-76. doi: 10.1007/s10103-015-1717-6. Epub 2015 Jan 30.
3
The clinical use of bone morphogenetic proteins revisited: a novel biocompatible carrier device OSTEOGROW for bone healing.
骨形态发生蛋白的临床应用再探讨:一种用于骨愈合的新型生物相容性载体装置OSTEOGROW
Int Orthop. 2014 Mar;38(3):635-47. doi: 10.1007/s00264-013-2201-1. Epub 2013 Dec 19.
4
Metrical and histological investigation of the effects of low-level laser therapy on orthodontic tooth movement.低水平激光疗法对正畸牙齿移动的计量和组织学研究。
Lasers Med Sci. 2012 Jan;27(1):131-40. doi: 10.1007/s10103-010-0853-2. Epub 2010 Oct 31.
5
Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence.骨形态发生蛋白与破骨细胞谱系细胞的相互作用:现有证据综述
Osteoporos Int. 2007 Dec;18(12):1565-81. doi: 10.1007/s00198-007-0441-x. Epub 2007 Aug 12.
6
Osteoclasts prefer aged bone.破骨细胞更喜欢老化的骨骼。
Osteoporos Int. 2007 Jun;18(6):751-9. doi: 10.1007/s00198-006-0298-4. Epub 2007 Jan 10.
7
Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12.根据细胞培养底物的不同,人类破骨细胞表达不同的CXC趋化因子:CXCL10和CXCL12高水平的分子及免疫细胞化学证据。
Histochem Cell Biol. 2003 Nov;120(5):391-400. doi: 10.1007/s00418-003-0587-3. Epub 2003 Nov 5.
8
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.骨保护素(OPGL)的配体可直接激活成熟破骨细胞。
J Cell Biol. 1999 May 3;145(3):527-38. doi: 10.1083/jcb.145.3.527.